Targeted therapies in the management of Colorectal cancer

Targeted therapies in the management of Colorectal cancer

Detalhes bibliográficos
Autor principal:	Maughan, T
Formato:	Conference item
Publicado em:	2011

Registos relacionados

Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
Por: Adams, R, et al.
Publicado em: (2007)

Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer
Por: Rustam Effendi-YS
Publicado em: (2022-07-01)

Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer.
Por: Clements, D, et al.
Publicado em: (2009)

CEA-targeted monoclonal antibody therapy in colorectal cancer
Por: Conaghan, P, et al.
Publicado em: (2009)

Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
Por: Patrick W. Underwood, et al.
Publicado em: (2024-01-01)

The Effective Role of Targeted Therapy in Advanced Colorectal Cancer
Por: Sarah K. Obay, et al.
Publicado em: (2022-07-01)

Signaling pathways in colorectal cancer: implications for the target therapies
Por: Yanlin Song, et al.
Publicado em: (2024-06-01)

Progress of research on molecular targeted therapies for colorectal cancer
Por: Shilin Huang, et al.
Publicado em: (2023-08-01)

New developments in targeted therapy for metastatic colorectal cancer
Por: Ambrose H. N. Wong, et al.
Publicado em: (2023-01-01)

Targeted splicing therapy: new strategies for colorectal cancer
Por: Yifeng Zheng, et al.
Publicado em: (2023-08-01)

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
Por: Sun Weijing
Publicado em: (2012-10-01)

Screening of potential molecular targets for colorectal cancer therapy
Por: Kimi Honma, et al.
Publicado em: (2009-11-01)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
Por: Prashanth Rawla, et al.
Publicado em: (2019-07-01)

Study on the Targeted Therapy of Colorectal Cancer with Multiple Pathway
Por: Zhou Junheng
Publicado em: (2024-01-01)

The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
Por: Abdo Meyiah, et al.
Publicado em: (2025-03-01)

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
Por: Adams, R, et al.
Publicado em: (2008)

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Por: Heng, Fong Seow, et al.
Publicado em: (2016)

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Por: Qing Li, et al.
Publicado em: (2024-10-01)

EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
Por: Balakarthikeyan Janani, et al.
Publicado em: (2022-03-01)

Targeting VCP potentiates immune checkpoint therapy for colorectal cancer
Por: Fang Wang, et al.
Publicado em: (2023-11-01)

Strategy to targeting the immune resistance and novel therapy in colorectal cancer
Por: Wang Gang, et al.
Publicado em: (2018-05-01)

Effect of gut microbiota in the colorectal cancer and potential target therapy
Por: Junchuan Li, et al.
Publicado em: (2022-06-01)

The c-Met receptor: Implication for targeted therapies in colorectal cancer
Por: Elmira Safaie Qamsari, et al.
Publicado em: (2017-04-01)

Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models
Por: Fortuné M. K. Elekonawo, et al.
Publicado em: (2019-12-01)

Metastatic colorectal cancer-prolonging overall survival with targeted therapies
Por: Satya Dattatreya
Publicado em: (2013-01-01)

A pilot study of the use of Oxaliplatin in metastatic colorectal cancer at Velindre
Por: Mitra, S, et al.
Publicado em: (2001)

Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
Por: Li Kuiyuan, et al.
Publicado em: (2009-04-01)

Editorial: Molecular mechanisms and targeted therapies for colorectal cancer vol II
Por: Alessandro Passardi, et al.
Publicado em: (2025-02-01)

The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy
Por: Yaohua Wei, et al.
Publicado em: (2024-08-01)

Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer
Por: Jörg Trojan, et al.
Publicado em: (2017-01-01)

Focused Ultrasound as Targeted Therapy for Colorectal Cancer: A Comprehensive Review
Por: Muhammad Awais Farooqi, et al.
Publicado em: (2024-04-01)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
Por: Furong Li, et al.
Publicado em: (2023-10-01)

Second-line targeted therapy for metastatic colorectal cancer. Possibilities for choices
Por: L. V. Bolotina, et al.
Publicado em: (2018-11-01)

Targeted drugs in the second line anticancer therapy of disseminated colorectal cancer
Por: K. A. Vorontsova, et al.
Publicado em: (2015-12-01)

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
Por: Lu Zhan, et al.
Publicado em: (2023-08-01)

Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Por: S. Cherradi, et al.
Publicado em: (2017-06-01)

Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
Por: Hull R, et al.
Publicado em: (2020-10-01)

Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer
Por: Tong Shen, et al.
Publicado em: (2021-03-01)

Current targeted therapies in the treatment of advanced colorectal cancer: a review
Por: Andrew Moriarity, et al.
Publicado em: (2016-07-01)

Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer
Por: Hannah Shailes, et al.
Publicado em: (2022-05-01)